Nasogastric and intravenous erythromycin as prokinetic in intensive care patients: a randomized controlled study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN61956055

Enrollment

Registered

2003-09-12

Start date

2002-01-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Signs and Symptoms: Signs and Symptoms Gastric emptying

Interventions

Nasogastric erythromycin compared to intravenous erythromycin

Eligibility

Inclusion criteria

Inclusion criteria: Patients who exhibit a failure to absorb nasogastric feed

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026